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ABSTRACT 
Objective: Bhasmas are traditional Indian medicinal preparations that are standardized using quality control tests prescribed by Ayurveda and 
other guidelines. There is a need to study the adequacy of the existing quality control tests and to correlate these to the performance of the product. 
No attempt has been made in the literature to study the adequacy of these tests in determining the biological activity of a product and to suggests 
new analytical techniques for determining the quality. In the present work, an attempt has been made to compare marketed samples of Mandur 
bhasma with respect to various existing quality control tests and to analyze these samples using modern analytical techniques for the complete 
analysis of Mandur Bhasma. Adequacy of all the tests and techniques was studied with respect to the hepatoprotective activity of mandur bhasma in 
paracetamol induced hepatotoxicity in rats. 
Methods: The marketed products of three leading brands of Mandur Bhasma were analyzed for quality-control tests as prescribed by Ayurveda and other 
guidelines. These samples were also analysed using modern analytical techniques like AAS, IR, XRD, HPTLC, SEM. These formulations were then evaluated for 
their hepatoprotective activity in paracetamol induced hepatotoxicity in rats and the results obtained were correlated with analytical results. 
Results: It was found that all the three bhasma samples were passing in quality control tests as prescribed by Ayurveda and other guidelines. These 
samples produced similar results when analyzed using AAS and IR. The results were different when analyzed using colorimetry, HPTLC, SEM and 
XRD. The extent of hepatoprotection in rats with paracetamol induced hepatotoxicity was also found to be different in the three samples. 
Conclusion: The analysis was carried out on three different marketed samples, and a correlation has been reported. It was seen that although all the three 
formulations passed traditional quality control tests and the tests laid by regulatory guidelines, but still there were significant differences in their biological 
activity. Analysis of iron content using colorimetric method was found to be discriminating in estimating the biologically effective form of iron. It was also 
found that HPTLC, XRD and SEM should be further developed and validated as analytical tools in determining the quality of Mandur bhasma product.  
Keywords: Mandur bhasma, Colorimetry, IR, AAS, SEM, XRD, HPTLC, Hepatoprotective activity 
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INTRODUCTION 
Ayurveda describes Bhasma as metallic/mineral preparations 
treated with plant juices and calcination at a high temperature in an 
earthen pot [1, 2]. During the bhasmikaran process, metals are 
converted into special chemical compounds that have desirable 
therapeutic activity. The Ayurveda reports Nischandratva, 
Rekhapurnatvam, Varitaratavam, and Amla pariksha as quality 
control tests for Bhasma [3, 4]. All these tests are the indicative of 
the formation of fine particles where metal has completely changed 
its physical and chemical properties. These tests depend upon 
physical observation which may be recorded with personal bias and 
hence are not free from the errors. Other tests like total ash, acid 
insoluble ash, loss on drying, etc. are also carried out but these tests 
are not indicative of quality, efficacy and safety of the bhasma.  
Hence, there is a need for the new methods of standardization for 
bhasma that can confirm its identity, quality, efficacy and safety with 
minimum error. The various modern analytical techniques like atomic 
absorption spectroscopy (AAS), X-ray diffraction (XRD), X-ray 
fluorescence (XRF), scanning electron microscopy (SEM), transmission 
electron microscopy (TEM), energy dispersive X-ray analysis (EDX), 
infra-red spectroscopy (IR), thermogravimetric analysis (TGA) etc. 
find their application in the analysis of bhasma [5-8].  
Mandur Bhasma is indicated for the treatment of various types of 
anaemia and jaundice. Hepatoprotective activity of Mandur Bhasma 
has been studied in CCl4
MATERIALS AND METHODS 
 induced liver toxicity [9]. It has also been 
found to show lipolytic [10] and hematinic activity [11]. Like other 
bhasma products Mandur bhasma is also analyzed using traditional 
quality control tests and tests prescribed by guidelines only. No 
studies are reported that correlate the results obtained from 
analytical techniques to the efficacy of the bhasma in general and 
Manudur Bhasma in particular. In the present work three different 
marketed products of Mandur Bhasma were analysed using 
traditional tests described by Ayurveda, physicochemical evaluation 
and instrumental techniques like UV spectroscopy, AAS, SEM, 
HPTLC, XRD and IR spectroscopy. These formulations were also 
analysed for the evaluation of hepatoprotective activity in 
paracetamol induced hepatotoxicity in rats and the results obtained 
were correlated with analytical results. 
Materials 
The marketed products of three leading brands of Mandur Bhasma 
were purchased from the market and were labeled as Mb1, Mb2 and 
Mb3. Paracetamol was gifted by Zim laboratories Ltd. Nagpur. All 
other reagents and chemicals were of analytical grade. 
Methods 
All the three marketed products were analyzed using following tests:  
Organoleptic characteristics  
The formulations of the bhasmas were observed physically, and their 
color, odor and touch were recorded. For testing touch the bhasma 
sample was taken in between the thumb and Index finger, rubbed 
and feel was observed. 
Physico-chemical characters 
Total ash 
About 2 gm of accurately weighed bhasma of each brand was 
incinerated in a silica dish at a temperature not exceeding 450 °C 
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until it was free from carbon. It was then cooled and weighed. The % 
w/w of ash with reference to the air-dried drug was calculated [12]. 
Acid insoluble ash 
Ash obtained in above test was boiled with 25 ml dilute HCl (6N) for 
five minutes. The insoluble matter was collected on an ashless filter 
paper, washed with hot water and ignited at a temperature not 
exceeding 450˚C to a constant weight [12]. 
Loss on drying About 2 gm of accurately weighed bhasma sample of 
each brand was placed in tared LOD bottle, and it was then placed in 
an oven at 110 °C for 1 h and weighed. Drying was continued till 
there was no difference between two successive weighing. Percent 
loss in weight was recorded [12]. 
Traditional quality control tests 
The samples of bhasma were analyzed using the following tests 
described in Ayurvedic textbooks:  
• Nischandratva 
The bhasma samples were taken in a Petri dish separately and 
observed for any luster in daylight through a magnifying glass. No 
luster was observed in the case of Mb1, Mb2 and Mb3. 
• Rekhapurnatvam 
 A pinch of Mb1 was taken in between the thumb and index finger 
and rubbed. It was observed that particles entered the lines of the 
finger and were not easily removed from the cleavage of the lines. 
The same observation was made for Mb2 and Mb3. 
• Varitaratavam 
A small amount of Mb1, Mb2 and Mb3 was sprinkled over the still 
water in separate beakers. Bhasma particles of all the samples were 
found to be floating on the surface of the water. 
• Amla pariksha 
A pinch of Mb1, Mb2 and Mb3 was mixed with a little amount of curd 
separately and observed for color change. No color change of curd 
was observed. The same procedure was followed with lemon juice 
taken in a test tube, and the same results were observed. 
Novel analytical methods used for standardization 
Quantitative estimation of Iron by colorimetric method  
Sample solution: About 20 mg of Mb1 was taken in a beaker and 
dissolved in 10 ml concentrated HCl using heat. It was then diluted 
to 100 ml with water. About 20 ml of this solution was further 
diluted to 100 ml with acetate buffer. The same procedure was 
repeated with Mb2 and Mb3. 
Standard solution: About 100 mg of ferric ammonium sulphate was 
dissolved in a little amount of water and 10 ml dilute HCl was added 
to it and diluted to 500 ml with water. 
Hydroxylamine hydrochloride solution was added to the standard 
and all the sample solutions followed by the o-phenanthroline 
solution. The color developed was measured at 515 nm on the UV-
Visible spectrophotometer. Iron content in the samples was 
measured in triplicate by comparing with the standard solution [13]. 
Elemental analysis by atomic absorption spectroscopy 
The elemental analysis was carried out using atomic absorption 
spectrometer Shimadzu AA6300. About 100 mg of sample was 
dissolved in 6.3 ml of nitric acid in 100 ml volumetric flask and 
volume was made up by distilled water. Then sample solution was 
aspirated into the flame. Before it enters the flame, the solution 
gets dispersed into a mist of very small droplets which evaporated 
in the flame to give the vapour of salts. Part of vapour will be 
dissociated into atoms of the elements to be measured. The studies 
were done in triplicate. 
The chemical composition of the selected sample was established 
through AAS analysis which directly gives % of constitute elements.  
Scanning electron microscopy 
Scanning electron microscopy (SEM) was done using Desktop SEM 
(FEI, Phenom). The samples were mounted on the stubs and images 
were recorded. 
HPTLC analysis 
A Camag HPTLC system was used for this study. Accurately weighed 
0.252 mg of Bhasma Mb1, Mb2 and Mb3 was dissolved in 10 ml of 
methanol separately and warmed. About 0.1 ml HCl was added to it 
and heated until dissolved. This solution after diluting with water 
was then spotted on the plate [Merck Silica Gel 60 254F 
X-ray diffraction study 
Aluminum 
(10x10 Cm)] and it was developed in TLC chamber containing the 
mobile phase. After development, the plate was air dried and then 
scanned in UV-VIS range of 595 nm in Camag TLC scanner.  
The X-ray diffractograms were obtained using X-Ray diffraction 
instrument (Philips Analytical-X’Pert PRO) with Ni-filtered Cu 
radiation, at a voltage of 40kV and current of 30mA. The scanning 
speed was 2 degree/min between 2 and 40 thetas.  
Infrared spectroscopic analysis 
The FTIR spectrum (Shimadzu IR affinity-I) was recorded using the 
wavelength range of 4000-200 cm-
Evaluation of hepatoprotective activity 
1. The scanning and recording 
speeds were set at the normal position. The sample was prepared by 
KBr pellet technique. About 2 mg of sample and 300 mg of 
potassium bromide powder IR grade (200-400 mesh) were mixed in 
a pastel and mortar and placed in a 13 mm die. The die was 
connected to the vacuum for 10 min. and a pressure of about 10-15 
tonnes was applied for 5 min. The prepared disk was then placed on 
a holder and scanned.  
Healthy male adult Wistar albino rats having the body weight (150-
200 g) were used. The temperature and humidity were maintained 
at 22 °C (±3 °C) and 50-60% respectively. Lighting was artificially 
maintained for 12 h dark and 12 h light. Animals were kept in the 
cages for at least 5 d prior to dosing for acclimatization to the 
laboratory conditions. 
Animals were used after approval by Institutional animal ethics 
committee and procedures were performed in accordance with the 
rules of Institutional animal ethics committee by CPCSEA 
(GNCP/IAEC/2011-2012/PC-3). 
Animals were divided into five groups. Each group contained six 
animals. Bhasma samples of Mb1, Mb2 and Mb3 were prepared in 
2% gum acacia and administered at a dose of 1 mg/100 gm of 
body weight was administered orally to each animal of group III, 
IV and V for 7 d. On the eighth day, Paracetamol (3 gm/kg orally) 
suspension in sterile distilled water was administered orally to all 
the three treated groups and one hepatotoxic control group 
(Group II) [10, 16, 20].  
• Treatment protocol  
Group I: Normal control (n=6, the animals were given normal saline 
only) 
Group II: Hepatotoxic control (n=6, the animals were given 
paracetamol on 8th
Group III: -Treatment group (n=6, the animals were given Mb1 for 
7Days and paracetamol on 8
 day) 
th
Group IV: Treatment group (n=6, the animals were given Mb2 for 
7Days and paracetamol on 8
 day) 
th
Group V: Treatment group (n=6, the animals were given Mb3 for 
Days and paracetamol on 8
 day) 
th
Rats were treated as per the treatment protocol. Body weights of 
these rats were monitored sequentially in control and experimental 
animals for a period of 8 d and blood sample was collected from 
retro-orbital puncture method after 24 h of toxicity induction.  
 day) 
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Biochemical estimation  
Serum was separated by centrifugation at 15000 rpm at 30 °C for 15 
min. The serum was then analyzed for various biochemical 
parameters like serum glutamate oxaloacetate transaminase (SGOT), 
serum glutamate pyruvate transaminase (SGPT) and alkaline 
phosphatase (ALP), Total protein and Bilirubin using standard kits 
manufactured by Ranbaxy Diagnostics Ltd. [15-17]. 
Statistical analysis 
The values were expressed as mean±SD. The statistical analysis was 
carried out by one-way analysis of variance (ANOVA) followed by 
Dunnet’s‘t’-test. P values<0.05 were considered significant. The 
results are given in table 6. 
Histopathological studies 
Finally, the animals were sacrificed after 48 h of Paracetamol 
administration and liver was isolated. The weight of each liver was 
taken and then histopathology of the liver samples was carried out. 
The liver tissue was excised from the animals, washed with normal 
saline to remove blood, fixed in 10 % buffered neutral formalin for 
12 h and processed for paraffin embedding. Section of 5μm 
thickness was cut using rotary microtome. The sections were 
processed and passed through graded alcohol series, stained with 
haematoxylin and eosin, cleaned in xylene and coverslipped in DPX. 
Histological examination was done under 10 X magnification using 
the microscope for degeneration, fatty changes, necrotic changes 
and evidence of hepatotoxicity if any [16].  
RESULTS AND DISCUSSION 
Analysis of the organoleptic characteristics of three marketed 
samples showed that Mb1 was black in color while Mb2 and Mb3 
were dark brown in color. The color in the case of all formulations is 
a very strong indicator of the quality of the product. In this case, it 
may indicate that Mb2 and Mb3 are of same quality and these two 
differ from Mb1. All the formulations were odorless and smooth to 
touch (Table1). Both Mb1 and Mb2 were found to exhibit LOD values 
of 0.20% and 0.21% which was well below the limit (0.40%) set by 
Ayurvedic Pharmacopoeia for Bhasma. Mb3 samples showed LOD 
value of 0.54% and thus it was not complying this test. All the three 
bhasma samples were showing total ash values as 33.14%, 35.53% 
and 39.86 %w/w for Mb1, Mb2 and Mb3 and thus were within the 
limits of 40.53% set by Ayurvedic Pharmacopoeia. Similarly acid 
insoluble ash values were also within the limits of 19.08% for all the 
three formulations (table 1). Thus, it can be stated that the selected 
three marketed formulations were passing the recommended 
physicochemical tests except for Mb3 which was not complying to 
the limit of LOD. 
When analyzed using traditional techniques for Bhasma evaluation 
suggested by Ayurveda, it was found that all the three formulations 
were complying these tests (table 2). It means that all the three 
formulations were devoid of metallic luster, particles got into the 
lines of fingers, floated on the water and did not show any reaction 
towards acids. On the basis of these tests, it can be concluded that 
the selected formulations were of equal quality as per traditional 
quality control tests for bhasma.  
Quantitative estimation of iron by colorimetric method revealed that 
iron content in Mb1, Mb2 and Mb3 were 51.07%, 38.05% and 
39.75% (table 3) while the iron content measured by AAS method 
was 57.32%, 55.62% and 50.76%. respectively (table 4). AAS has 
been used earlier for the determination of contents of different 
elements in bhasma samples by some researchers [18]. 
Determination of iron content in both the methods is based on 
different principles. In colorimetric it is based on the formation of 
colored complex between ferrous ion and o-phenanthroline. The 
presence of iron in ferrous state is ensured by hydroxylamine 
hydrochloride which converts any ferric ions to ferrous ions. But no 
data is available in the literature with regard to the state of the iron 
present in Bhasma. Depending upon the treatment given to Iron 
during bhasmikaran, it can be present in different oxidative states 
ranging from-2 to+6. A reducing agent like hydroxylamine 
hydrochloride will be able to reduce only the iron that is present in 
oxidation state higher to+2, but it will not have any effect on lower 
oxidation states. While in the case of AAS, all the iron is first 
converted into free atoms and then it is estimated. This ensures that 
iron present in all the forms gets determined. Thus colorimetric 
method discriminates between the different oxidative forms of iron 
while AAS does not. This explains the variations in the results 
obtained by both the methods revealing that iron is present in 
different states depending upon the bhasmikaran process. This 
finding is particularly important considering the use of metals in the 
treatment of diseases both from efficacy and safety point of view. 
Highest iron content in Mb1 shows that in Mb1 iron is present in 
oxidation state higher to+2. Thus, colorimetric test discriminates 
between the different samples based on the form of the iron present. 
The process of bhasmikaran causes changes to the metal and there is 
a need to standardize the final product with respect to biological 
activity [19].  
Scanning electron micrographs of Mb1, Mb2 and Mb3 are given in 
fig. 1. It can be seen that these samples are composed of numerous 
very small sized particles along with some bigger particles, closed 
examinations of SEM of Mb1 reveals that even the surface of bigger 
particles is completely covered with very tiny particles while the 
similar features could not be seen in SEM of Mb2 and Mb3. Further 
the particles of Mb1 seen to have very rough and porous surface. To 
some extent this feature can also be seen in Mb3 while all the Mb2 
particles show more or less smooth surfaces. The non-similarity in 
the SEM images of three different formulations reveals that these 
may differ in their biological activity also if the particle size and 
shape plays a role in the mechanism of action of this bhasma. 
Further characterization of the bhasma particles and fixing their 
limits can act as a quality determinant tool. 
Additionally in the process of bhasmikaran, metals are treated with 
plant juices that may result in the presence of organic or organo-
metallic compounds. So there was a need to establish the content of 
these compounds present in the bhasma. HPTLC was carried out in 
view of that. As shown in fig. 2 it was found that a part of the applied 
spot of MB1 could travel some distance indicating the presence of 
some organic compounds, while the major part didn’t travel at all 
with mobile phase, indicating its polar nature. With Mb2, a part of 
the spot could move with mobile phase but with great tailing effect. 
This means Mb2 consisted of a mixture of organic or organometallic 
compounds. The density of the spot of Mb3 was highest at its origin 
point, and there was the movement of a trace quantity of the applied 
spot, indicating the presence of a very little quantity of organic or 
organometallic compounds in this Bhasma. But, however little the 
organic material is, its quantification using HPTLC will determine 
the quality of bhasma more accurately. Thus, HPTLC can be 
developed as a potential analytical tool for the bhasmas.  
XRD diffraction pattern of the selected Bhasma is shown in fig. 3. The 
presence of sharp crystalline peaks shows the presence of the 
crystalline material. But diffraction patterns of these samples are not 
matching exactly. The XRD diffractograms of Mb1, Mb2 and Mb3 are 
showing three common peaks approximately at 30.4, 33.5 and 35.9 
(table 5). Out of these peaks at 33.5 and 35.9 are due to iron oxide 
[20]. Mb1 and Mb2 are showing additional peaks at 43.44 and 43.39 
respectively indicating the presence of iron oxide. Mb3 is showing 
the additional peak of iron oxide at 24.53. Further work is required 
to identify additional peaks in the diffractograms of these 
formulations to understand the nature of their constituents better.  
IR spectroscopy was also done with the same objective. Results are 
given in fig. 4. IR spectra of Mb1 reveals the presence of some 
organic bonds because of the appearance of peaks at 3750, 2425, 
1750, 1680, 1650, 1550 and 1510 cm-1. These bonds may be due to 
N-H stretch, C=O stretch and other functional groups that are 
normally present in organic compounds. The spectra also reveal the 
presence of bands in the low-frequency region like 880, 572, 450 
and 402 cm-1. The bands in this region are mainly because of iron 
and its oxides. Broad nature of the bands suggests the presence of 
the mixture of compounds. Although these results are in consistence 
with the results obtained by HPTLC, but IR basically being 
qualitative in nature can only act as supporting tool and not as the 
dependable tool for deciding the quality of bhasma.  
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The IR spectra of Mb2 indicate the presence of organic bonds, but 
the lower intensity of the bands at 3750, 2350, 1510, 1026 and 966 
cm-1 reveals that the functional groups responsible for these bonds in 
organic compounds are present in very less quantity as compared to 
Mb1. The sharp bands appearing in the region lower than 600 cm-1 
shows that iron oxides present in this region are of some distinct nature. 
The IR spectra of Mb3 showed the complete absence of bands owing 
to bonds of organic compounds. This finding was consistent with the 
results obtained by HPTLC where very trace compound travelled 
with the non-polar mobile phase. A broad peak at 1015 cm-1and few 
peaks below 500 cm-1
Mandur Bhasma is indicated for its hepatoprotective activity. The 
hepatoprotective activity of these marketed samples was evaluated by 
measuring the levels of serum marker enzymes like SGOT, SGPT and ALP 
in the rats with paracetamol induced hepatotoxicity [21]. The serum 
levels of total proteins and bilirubin were also determined. All the 
formulations were found to reduce the levels of SGOT, SGPT, ALP and 
bilirubin markedly but Mb1 was found to be most effective amongst all 
(table 6). Similarly, all the three formulations were successful in raising 
serum levels of total proteins and the group treated with Mb1 could 
elevate the total proteins to 6.15 g/dl as against 5.91 & 5.96 in the case of 
groups treated with Mb2 and Mb3 respectively. 
 indicated the iron present in different forms. 
The effectiveness of Mb1 as better hepatoprotective was also 
supported by the results of histopathological studies (fig. 5). These 
studies revealed that paracetamol caused 80% to 85% necrosis of 
liver and treatment with Mb1 could reduce it to 5% to 10%. While 
the rats treated with Mb2 and Mb3 could reduce the necrosis to 30% 
to 40% and 50% to 60% only. This shows that Mb1 was most 
effective in protecting the liver from paracetamol induced 
hepatotoxicity. Obviously, the physicochemical properties of the 
Mb1 must be responsible for the better biological activity.  
Which means that black color of the product, about 50 % of iron content 
as determined by colorimetry, presence of organic matter as indicated 
by HPTLC and IR, characteristic XRD pattern and tiny and rough 
particles as seen in SEM, may be the indicator of the good quality of 
bhasma. There is further need for developing and validating HPTLC, XRD 
and SEM as the analytical tools for bhasma in general and Mandur 
bhasma in particular. This work reveals that traditional quality control 
tests and pharmacopoeial quality control tests may not be sufficient in 
evaluating the quality of Mandur bhasma. Thus additional techniques as 
revealed in this work are required to be developed further and must be 
included in the pharmacopoeia along with their desired specifications. 
 
Table 1: Results of Physico-chemical characterization 
Parameter Standard limits *(%w/w) Observation 
Mb1 (%w/w) Mb2 (%w/w) Mb3 (%w/w) 
Colour -- Black Dark brown Dark brown 
Odour -- Odourless Odourless Odourless 
Touch -- Smooth Smooth Smooth 
Loss on drying Not more than 0.40 0.20 0.21 0.54 
Total Ash Not more than 40.53 33.14 35.53 39.86 
Acid Insoluble Ash Not more than 19.08 15.08 18.41 18.27 
*Ayurvedic pharmacopeia 
 
Table 2: Results of traditional quality control test 
Techniques  Observation 
Mb1 Mb2 Mb3 
Nischandratva Complies Complies Complies 
Rekhapurnatvam Complies Complies Complies 
Varitaratavam Complies Complies Complies 
Amla pariksha Complies Complies Complies 
 
Table 3: Results of Quantitative estimation of Iron by colorimetry 
Constituent Standard limits (% w/w)[14] Sample Result (%w/w)* 
Iron (by UV) Not more than 62.7 Mb1 51.07 
Mb2 38.05 
Mb3 39.75 
* Average of three measurements 
 
Table 4: Results of quantitative estimation of elements by atomic absorption spectrometry 
S. No. Constitute Symbol Standard limits (%w/w) % of constituents* 
Mb1 Mb2 Mb3 
1 Iron Fe NMT 62.7 57.32 55.62 50.76 
2 Sodium Na NMT 1.70 1.21 1.05 1.45 
3 Magnesium Mg NMT 3.987 2.88 2.45 2.98 
* Average of three measurements 
 
Table 5: Different crystal peak list of Mb3 
Mb1 Mb2 Mb3 
Pos. [ °2Th.] d-spacing [Å] Pos. [ °2Th.] d-spacing [Å] Pos. [ °2Th.] d-spacing [Å] 
 18.7050  4.74399   21.1580 4.19921 
 26.9155  3.31260   24.5398 3.62765 
 30.4278  2.93777 30.5570 2.92564 26.9319 3.31062 
 33.4931  2.67558 33.5289 2.67280 30.0765 2.97127 
 35.7725  2.51014 35.9746 2.49651 33.4919 2.67567 
 43.4450  2.08126 43.3963 2.08521 35.9576 2.49765 
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Table 6: Results of Effect of different formulation of Mandur bhasma on serum parameters in paracetamol induced (3g/kg, b. w) hepatic 
damage in rats 




Treatment group (III) 
Mb1 
Treatment group (IV) 
Mb2 
Treatment group (V) 
Mb3 
SGOT (IU/l) 69.16±5.68** 135.83±4.72** 110.83±5.68** 120.33±4.63** 128.00±5.88** 
SGPT (IU/l) 85.00±5.15** 130.32±5.62** 115.14±5.77** 118.12±5.27** 120.24±6.54** 
ALP (IU/l) 380.00±9.39** 575.17±18.01** 424.83±5.86* 436.50±11.16** 481.67±8.22** 
Bilurubin (mg/dl) 0.78±0.03** 1.00±0.03** 0.46±0.04** 0.48±0.03** 0.63±0.02* 
Protein (gms/dl) 7.76±0.48** 5.75±0.40** 6.15±0.33* 5.91±0.30** 5.96±0.35** 
Albumin (gms/dl) 4.41±0.11** 3.45±0.12** 3.75±0.18** 3.56±0.29** 3.59±0.12** 
Creatinine (mg/dl) 1.48±0.11** 3.35±0.17** 2.51±0.13** 2.75±0.16** 3.13±0.19** 
Urea (mg/dl) 48.16±3.01* 73.68±6.67* 70.83±6.55* 71.58±6.78* 72.65±6.75* 
(*) and (**
 
) represents that values were P<0.05 and P<0.01 considered to be significant, No. of animals for each measurement = 6, (SGOT: serum 
glutamate oxaloacetate transaminase, SGPT: serum glutamate pyruvate transaminase, ALP: alkaline phosphatise)  
 




Fig. 2: Thin layer chromatography analysis of Mb1, Mb2 and 





Fig. 3: The X-ray patterns of Mb1 (A), Mb2 (B) and Mb3 (C) 
 
 
Fig. 4: The FT-IR spectra of Mb1 (A), Mb2 (B) and Mb3 (C) 
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Fig. 5: a: Section of liver control group; b: section of 
paracetamol treated group liver; c: paracetamol+mb1 treated 
group; d: paracetamol+mb2 treated group; e: 
paracetamol+mb3 treated group 
 
CONCLUSION 
The purpose of this work was to determine the ability to exist 
analytical tests and to explore the potential of modern analytical 
tools which can discriminate between two Mandur Bhasma 
formulations based on their biological effectiveness. It was seen that 
although all the three formulations passed traditional quality control 
tests and the tests laid by Ayurvedic Pharmacopoeia, but still there 
were significant differences in their biological activity. Analysis of 
iron content using colorimetric method was found to be 
discriminating in estimating the biologically effective form of iron. 
AAS was not helpful in this regard mainly because of its efficiency of 
determining iron in all the possible forms. HPTLC and IR studies 
indicated the presence or absence of organic matter in this 
herbometallic formulation. Further work is required to standardize 
the organic matter present in this with the help of both of these 
techniques. The use of XRD data can also be made in depicting the 
biological activity of these formulations. Thus, with the help of some 
further work tests for the standardization of Mandur Bhasma can be 
devised and limits can be established which will ensure a uniform 
biological activity. 
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